Eurofirst News: Eurofirst 100, Eurofirst 250, and Eurofirst 500 investment news
Eurofirst market news from the Euronext Stock Exchange: Eurofirst 100, Eurofirst 250, and Eurofirst 400

Latest Eurofirst News:

  • European carmakers higher on Nissan gains

  • IBEX adds 1.42 percent on session

  • France Telecom gains over 8.5 percent on results

  • Banks see declines in Europe

  • European equities lower on renewed subprime worries

  • IBEX gains again amid European equities declines

  • Truck maker Man up on bids rumors

  • IBEX gains almost 1 percent on session

  • European utilities gain again

  • European equities lower on session

  • Euronext news feed


    Recommended equities news sites

  • Euronext
  • Euro Watch
  • FTSE News
  • Tokyo Market News
  • NYSE News
  • Mortgages & Loans
  •  

    November 13, 2006

    Deutsche Telekom up on change of chief executive

    Filed under: Novartis, Deutsche Telekom, Sacyr-Vallehermoso, Bilfinger Berger

    In Europe on Monday the FTSE Eurofirst 300 closed 0.2 percent higher to 1,466.64 as the corporate earnings season continued to produce more positive surprise than negative ones.

    In the construction sector, German group Bilfinger Berger added 1.7 percent to €48.40 after its first nine months were better than had been anticipated. The results earned the German builder an upgraded target share price from WestLB. Likewise, Spanish builder Sacyr Vallehermoso closed 15.2 percent higher to €54 on an increase in core earnings in its first nine months.

    Deutsche Telekom added 2.6 percent to €13.48 and went as high as €13.62 during the day on the news that its chief executive had resigned and been replaced by the head of its mobile phone unit. Broker reaction was mixed. Morgan Stanley stuck with its rating of “overweight” and raised its target share price for the German telecom company from €13.10 to €13.50. Bear Stearns, on the other hand, repeated its recommendation of “underperform”, saying that a new chief executive would not make much of a difference on a board where the union controls nearly half of the seats.

    Losers on the day included Novartis, which dropped 1 percent to SFr72.95 after it was announced that a US Food and Drug Administration decision on the approval of its diabetes drug, Galvus, for use in the United States, will be delayed for three months.





    Latest Equities News:

  • Wall Street ends lower despite rate cut

  • Asia-Pacific, Europe equities see declines

  • Hang Seng adds 10.72 percent on session

  • India’s Sensex drops 1,408 points on session

  • Australian markets drop for 9th straight day

  • Taiex gains on opposition win in parliamentary elections

  • Hang Seng drops nearly 400 points

  • Most Asia-Pacific markets drop on US recession worries

  • Tokyo declines on export worries

  • Asia-Pacific equities mixed on economic concerns

  • Eurofirst News copyright 2005 Central Consultants